FindTrial
Sign In

To look for any correlation of recurrence pattern occurring in Glioblastoma patients with respect to sub ventricular zone location as well as the the correlation of specific molecular markers; and also to sudy the radiation characteristics received by the sub ventricular zone

Patterns of failure and correlation of molecular markers with sub ventricular zone dosimetry in patients with newly diagnosed glioblastoma treated with conventional adjuvant therapy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2017/09/009941
Enrollment
100
Registered
2017-09-27
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Malignancy - Glioblastoma

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Tata Memorial Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Karnofsky Performance Status (KPS) >=70% 2. Newly diagnosed case of histopathologically proven glioblastoma WHO stage IV treated with radical intent 3. Glioblastoma supratentorial in origin

Exclusion criteria

Exclusion criteria: 1. Age 70yrs 2. Poor general condition and performance status (KPS 3. Prior history of irradiation or chemotherapy

Design outcomes

Primary

MeasureTime frame
Correlation of molecular markers (MGMT and IDH) and patterns of failure and survival with SVZ dosimetryTimepoint: Time frame from which data collected: September, 2012 â?? November, 2016—

Secondary

MeasureTime frame
NoneTimepoint: None—

Countries

India

Contacts

Public ContactRakesh Jalali

Tata Memorial Hospital

jalali.rakesh@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026